| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.59 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |